TFOS DEWS II management and therapy report

L Jones, LE Downie, D Korb, JM Benitez-del-Castillo… - The ocular …, 2017 - Elsevier
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Tfos dews ii iatrogenic report

JAP Gomes, DT Azar, C Baudouin, N Efron… - The ocular …, 2017 - Elsevier
Dry eye can be caused by a variety of iatrogenic interventions. The increasing number of
patients looking for eye care or cosmetic procedures involving the eyes, together with a …

Advances in dry eye disease treatment

EC O'Neil, M Henderson… - Current opinion in …, 2019 - journals.lww.com
Clinicians have more options at their disposal in the treatment of dry eye disease than ever
before, including topical medications and devices. SYNOPSIS In this article, we review …

[HTML][HTML] Dry eye management: targeting the ocular surface microenvironment

X Zhang, V Jeyalatha M, Y Qu, X He, S Ou, J Bu… - International journal of …, 2017 - mdpi.com
Dry eye can damage the ocular surface and result in mild corneal epithelial defect to
blinding corneal pannus formation and squamous metaplasia. Significant progress in the …

[HTML][HTML] Advances in the diagnosis and treatment of dry eye

T Kojima, M Dogru, M Kawashima, S Nakamura… - Progress in retinal and …, 2020 - Elsevier
The core mechanism of dry eye is the tear film instability. Tear film-oriented diagnosis
(TFOD) is a concept to clarify the cause of tear film instability by tear film, and tear film …

[HTML][HTML] Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction

R Arita, S Fukuoka, N Morishige - The Ocular Surface, 2019 - Elsevier
Purpose To evaluate the efficacy and safety of intense pulsed light (IPL) combined with
meibomian gland expression (MGX) for treatment of refractory meibomian gland dysfunction …

Management of meibomian gland dysfunction: a review

S Sabeti, A Kheirkhah, J Yin, R Dana - Survey of ophthalmology, 2020 - Elsevier
Meibomian gland dysfunction is the leading cause of evaporative dry eye disease and is
one of the most common conditions encountered by eye care providers. The disorder is …

TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface

JAP Gomes, DT Azar, C Baudouin, E Bitton, W Chen… - The Ocular Surface, 2023 - Elsevier
The word “elective” refers to medications and procedures undertaken by choice or with a
lower grade of prioritization. Patients usually use elective medications or undergo elective …

[HTML][HTML] Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape

JD Sheppard, KK Nichols - Ophthalmology and Therapy, 2023 - Springer
Meibomian gland dysfunction (MGD) is highly prevalent and is the leading cause of
evaporative dry eye disease (DED). MGD is characterized by a reduction in meibum …

[HTML][HTML] Intense pulsed light treatment in meibomian gland dysfunction: a concise review

B Tashbayev, M Yazdani, R Arita, F Fineide… - The ocular surface, 2020 - Elsevier
Purpose To review the published literature related to application of intense pulsed light (IPL)
for treating meibomian gland dysfunction (MGD). Methods The literature search included the …